Polygenic overlap between schizophrenia risk and antipsychotic response: a genomic medicine approach.
about
Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychoticsPKBγ/AKT3 loss-of-function causes learning and memory deficits and deregulation of AKT/mTORC2 signaling: Relevance for schizophrenia.Realising stratified psychiatry using multidimensional signatures and trajectories.Polygenic Risk Score for Schizophrenia and Treatment-Resistant Schizophrenia.Analysis of genome-wide association data highlights candidates for drug repositioning in psychiatry.Translating advances in the molecular basis of schizophrenia into novel cognitive treatment strategies.Toward development of epigenetic drugs for central nervous system disorders: Modulating neuroplasticity via H3K4 methylation.The road to precision psychiatry: translating genetics into disease mechanisms.Clozapine as a Model for Antipsychotic Development.Gene-set analysis based on the pharmacological profiles of drugs to identify repurposing opportunities in schizophrenia.Drug enrichment and discovery from schizophrenia genome-wide association results: an analysis and visualisation approach.Editorial: Improving Neuropharmacology using Big Data, Machine Learning and Computational Algorithms.Institutional profile: translational pharmacogenomics at the Icahn School of Medicine at Mount Sinai.Revisiting Antipsychotic Drug Actions Through Gene Networks Associated With Schizophrenia.New considerations for hiPSC-based models of neuropsychiatric disorders.Learning Opportunities for Drug Repositioning via GWAS and PheWAS Findings.Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and AgranulocytosisExpression-based drug screening of neural progenitor cells from individuals with schizophrenia
P2860
Q28079065-EC3696A3-760A-4D08-B68D-46516F9996C4Q29994856-546B67DB-2914-49F3-B15E-7F4CA11F549EQ37591548-6EC553F1-D033-4143-AB49-4299910F7CF4Q38402758-5028E215-10D4-4B5F-BF26-D06D32B7DF75Q38626082-5A228440-B34B-459B-BC95-1B4C763F6D2CQ38699013-041540CB-FA9D-473A-9975-7DDF4EF6714AQ38916715-C9002CD4-4EB9-4D98-AA2C-03FCF94A44F0Q38992286-685518E4-2A6C-41A6-AA54-6B20A02461D4Q39400094-CE76C7FD-7354-4FB1-A333-ACF09445F8ACQ39682696-FF944D60-040A-4A32-BDAA-4B0EEECB0644Q42266399-8D0C54F2-DCA5-4634-80EA-B24A47E6347BQ45943327-EF75CD7E-4B8B-4CC6-ABA4-AD0CDB68EEF5Q46293630-9BBEEF20-0D00-4F67-A57F-BA0E41D92890Q50421323-7E0CB41F-EBD4-4759-90DB-37E72A8B51C2Q52372478-25C792EA-A554-413A-90AF-6CEC3265B3DFQ55265756-E2583AD7-AB0B-420C-9FF8-ECB906750FB2Q57491589-A87080CE-A968-42F9-822E-7E89E914CC47Q57793573-F8A4E6B1-A116-40D4-8421-AEAD405C5A9C
P2860
Polygenic overlap between schizophrenia risk and antipsychotic response: a genomic medicine approach.
description
article científic
@ca
article scientifique publié en 2016
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 February 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Polygenic overlap between schi ...... : a genomic medicine approach.
@en
Polygenic overlap between schi ...... : a genomic medicine approach.
@nl
type
label
Polygenic overlap between schi ...... : a genomic medicine approach.
@en
Polygenic overlap between schi ...... : a genomic medicine approach.
@nl
prefLabel
Polygenic overlap between schi ...... : a genomic medicine approach.
@en
Polygenic overlap between schi ...... : a genomic medicine approach.
@nl
P2093
P2860
P50
P1476
Polygenic overlap between schi ...... : a genomic medicine approach.
@en
P2093
Alexander W Charney
Anna K Kähler
Ben Readhead
Brian A Kidd
Joel T Dudley
Pamela Sklar
Patrick F Sullivan
Paul J Kenny
Shaun M Purcell
P2860
P304
P356
10.1016/S2215-0366(15)00553-2
P577
2016-02-22T00:00:00Z